Albemarle (ALB) 10-K Summary — Year Ended Dec 31, 2025
Albemarle Corporation reported a net loss and negative operating income for the fiscal year, driven by a continued decline in revenue. Operating cash flow remained positive, providing some liquidity support.
Key takeaway
Year ended Dec 31, 2025 · FY2025 10-K
Albemarle Corporation reported a net loss and negative operating income for the fiscal year, driven by a continued decline in revenue. Operating cash flow remained positive, providing some liquidity support.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$5.1B
Revenue reported for the fiscal year.
Operating income
-$367.1M
Income from operations reported for the year.
Net income
-$510.6M
Net income reported for the year.
Operating cash flow
$1.3B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $7.3B | +120.0% |
| Dec 31, 2023 | $9.6B | +31.4% |
| Dec 31, 2024 | $5.4B | -44.1% |
| Dec 31, 2025 | $5.1B | -4.4% |
Business overview
Albemarle is a global specialty chemicals company. The Business overview section references Item 1, but no further descriptive text is provided in the supplied filing context. The company operates in the lithium, bromine, and catalyst segments.
Financial performance
Revenue declined compared to the prior year. The company reported an operating loss and a net loss for the period. Operating cash flow was positive, though profitability metrics were negative.
Material risks
The filing includes a dedicated Risk Factors section (Item 1A) that lists material risks, though specific risk descriptions are not extracted in the supplied JSON. These risks may include market conditions, regulatory changes, and operational challenges typical of the chemicals industry.
Liquidity and capital
Operating cash flow was positive, which may support capital allocation needs. No specific capital allocation themes or liquidity strategies are elaborated in the supplied context.
What to watch
Monitor whether the company can reverse its revenue decline and return to profitability in the next fiscal year.